TITLE

Use of a Registry to Improve Acute Stroke Care - Seven States, 2005-2009

AUTHOR(S)
George, M. G.; Tong, X.; Yoon, P. W.
PUB. DATE
February 2011
SOURCE
MMWR: Morbidity & Mortality Weekly Report;2/25/2011, Vol. 60 Issue 7, p206
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article examines the status of adherence to 10 performance measures to improve stroke care implemented by the Paul Coverdell National Acute Stroke Registry (PCNASR) in seven U.S. states from 2005-2009. Results of the study revealed that adherence to nine of the 10 performance measures increased significantly during the period except in antithrombotic therapy at discharge. Greatest overall improvement was with the use of thrombolytic therapy 11%, counseling on smoking cessation 9.2% and lipid testing and or treatment 7.6%.
ACCESSION #
59533239

 

Related Articles

  • Progress in managing stroke.  // Consumer Reports on Health;Feb2002, Vol. 14 Issue 2, p2 

    Reports the availability of treatment for strokes. Decline of fatalities from ischemic and hemorrhagic stroke; Effect of thrombolytic drugs on survival rate of patients; Management of high blood pressure and atrial fibrillation.

  • Editorial: Drugs in Interventional Cardiology. Radke, Peter W. // Current Pharmaceutical Design;Apr2008, Vol. 14 Issue 12, p1151 

    The article discusses various reports published within the issue, including one by Susanne Alban on the pharmacology of different antithrombotic drugs and another by Alexander Joost on anticoagulation problem in patients with confirmed or suspected heparin-induced thrombocytopenia (HIT).

  • Antithrombotic treatment before stroke onset and stroke severity in patients with atrial fibrillation and first-ever ischemic stroke: An observational study. Po, Helen L.; Ya-Ju Lin // Neurology Asia;Jun2010, Vol. 15 Issue 1, p11 

    Background and Objectives: Atrial fibrillation (AF) is an important, independent risk factor for stroke. The value of antithrombotic therapy to prevent stroke is well established in numerous randomized controlled trials. The objectives of this study were to determine the rate and the factors...

  • Stroke, Antithrombotics.  // Formulary;Feb2001, Vol. 36 Issue 2, p170 

    Updates on the status of stroke, antithrombotics development in the United States. Drugs and indications; Product type; Proposed indication; Food and Drug Administration (FDA) status. INSET: Selected published literature/Internet information to assist....

  • Fibrin Degradation Products and the Role of Coagulation in 'Persistent' Glomerulonephritis. Chirawong, Phisit; Nanra, Ranjit Singh; Kincaid-Smith, Priscilla // Annals of Internal Medicine;Jun71, Vol. 74 Issue 6, p853 

    Deals with a study which examined the role of the coagulation process in the pathogenesis of progressive glomerular lesions and the rationale for the use of antithrombotic and anticoagulant drugs in glomerulonephritis. Materials and methods used in the study; Results and discussion.

  • DRUG THERAPY TODAY. Rodman, Morton J. // RN;May81, Vol. 44 Issue 5, p79 

    Focuses on how to prevent the development of post-myocardial infarction thromboembolism. Types of anticoagulants; Significance of prophylaxis; Examples of thrombolytic agents.

  • Surgical and Anticoagulant Therapy of Occlusive Cerebrovascular Disease. Siekert, Robert G.; Whisnant, Jack P.; Millikan, Clark H. // Annals of Internal Medicine;Apr63, Vol. 58 Issue 4, p637 

    Studies the surgical and anticoagulant therapy of occlusive cerebrovascular disease. Stages of focal ischemic cerebrovascular disease; Atherosclerosis in ischemic cerebrovascular disease; Diagnosis of ischemic disease; Results of the surgical and anticoagulant therapy; Response of patients with...

  • Stroke prevention: Are anticoagulants used too often?  // Geriatrics;Oct96, Vol. 51 Issue 10, p15 

    Focuses on the research finding that anticoagulants are being often used in patients at risk of ischemic stroke, whereas many would be good candidates for carotid endarterectomy. Survey of physicians conducted by investigators from Duke University, Durham, North Carolina; Classic candidate for...

  • Treating acute ischaemic stroke. Bath, Philip M.W. // BMJ: British Medical Journal (International Edition);7/15/95, Vol. 311 Issue 6998, p139 

    Presents two sets of events related to drug treatments of ischemic stroke in Great Britain. Trials of anticoagulant treatment; Publication of the `Cochrane Database of Systemic Reviews' on disk; Six actions necessary for the development of short term treatments for stroke.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics